Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.
Article Details
- CitationCopy to clipboard
Manley PW, Allanson NM, Booth RF, Buckle PE, Kuzniar EJ, Lad N, Lai SM, Lunt DO, Tuffin DP
Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.
J Med Chem. 1987 Sep;30(9):1588-95.
- PubMed ID
- 3305945 [ View in PubMed]
- Abstract
Analogues of 4-[[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)methoxy]methyl] ethoxy]methyl]benzoic acid (5m) were prepared and evaluated as thromboxane synthase inhibitors. A series of esters of 5m showed a parabolic relationship between lipophilicity and inhibition of TxB2 generation in intact platelets, with activities up to 50 times greater than that of dazoxiben. However, on administration to rabbits the ethyl ester 5d had a short duration of action, due to rapid metabolism and excretion via deesterification and beta-glucuronidation. Attempts at replacing the carboxylate group with other potential pharmacophores were unsuccessful.
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Dazoxiben Thromboxane-A synthase IC 50 (nM) 1290 N/A N/A Details